Protective effects and mechanism of total coptis alkaloids on A β 25-35 induced learning and memory dysfunction in rats

Chinese Journal of Integrative Medicine

Volumn 13, Issue 1, 2007, Pages 50-54

  Yang, Zheng Qin ^a,b   Yang, Su Fen ^a   Yang, Jun Qing ^a   Zhou, Qi Xin ^a   Li, Shao Lin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

amyloid peptide; Learning and memory; Rat; Total coptis alkaloids

Indexed keywords

ALKALOID DERIVATIVE; AMYLOID BETA PROTEIN[25-35]; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; PLANT EXTRACT; THIOBARBITURIC ACID; TOTAL COPTIS ALKALOID DERIVATIVE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; COPTIS; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WISTAR RAT;

ALKALOIDS; AMYLOID BETA-PROTEIN; ANIMALS; CEREBRAL CORTEX; COPTIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; INJECTIONS; LEARNING DISORDERS; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; NF-KAPPA B; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; REACTION TIME; SUPEROXIDE DISMUTASE; SWIMMING;

EID: 34047273359     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-007-0050-8     Document Type: Article

References (15)

1. Erme M, Geula C, Ransil BJ, et al. The acute neurotoxicity and effects upon cholinergic axons or intracerebrallly injected beta-amyloid in the rat brain. Neurobiol Aging 1992;13:553-559.
2. Kowall NW, Beal MF, Busciglio J, et al. An in vivo model for the neurodegenerative effects of β -amyloid and protection by substance P. Proc Natl Acad Sci USA 1991;88:7247-7251.
3. Hensley K, Floyd RA, Zheng NY, et al. P38 kinase is activated in Alzheimer' s disease brain. J Neurochem 1999;72:2053-2058.
4. Rogers J, Webster S, Lue LF, et al. Inflammation and Alzheimer' s disease pathogenesis. Neurobiol Aging 1996;17:681-686.
5. Akama KT, Albanese C, Pestell RG, et al. Amyloid β -peptide stimulates nitric oxide production in astrocytes through an NF- κ B-dependent mechanism. Proc Natl Acad Sci USA 1998; 95:5795-5800.
6. Tjernberg LO, Naslund J, Thyberg J, et al. Generation of Alzheimer amyloid β -peptide through nonspecific proteoplysis. J Biol Chem 1997;272:1870-1875.
7. Guo YY, Zhang Y. Study of experimental pharmacology of coptis anti-toxin soup. Chin Tradit Patent Med 1993;15(8):29-31.
8. Zhou LJ, Song W, Zhu XZ, et al. Protective effects of bilobalide on amyloid beta-peptide 25-35-induced PC12 cell cytotoxicity. Acta Pharmacol Sin 2000; 21(1):75-79.
9. Morimoto K, Yoshimi K, Tonohiro T, et al. Co-injection of β -amyloid with ibotennic acid induces synergistic loss of rat hippocampal neurons. Neuroscience 1998; 84:479-487.
10. Ye JW, Shang YZ, Wang ZM, et al. Huperzine A ameliorates the impaired memory of aged rat in the Morris Water Maze performance. Acta Pharmacol Sin 2000;21(1):65-69.
11. Frautschy SA, Baird A, Cole GM. Effects of injected Alzheimer β -amyloid cores in rat brain. Proc Natl Acad Sci USA 1991;88:8362-8366.
12. Kowall NW, McKee AC, Yankner BA, et al. In vivo neurotoxicity of β -amyloid β (1-40) and the β (25-35) fragment. Neurobiol Aging 1992;13:37-42.
13. Clemens JA, Stephenson DT. Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol Aging 1992;13:581-586.
14. Games D, Khan KM, Soriano FG, et al. Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain. Neurobiol Aging 1992; 3:569-576.
15. Bales KR, Du Y, Dodel RC. The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Brain Res Mol Brain Res 1998;57:63-72.